vs
Axsome Therapeutics, Inc.（AXSM）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是Resolute Holdings Management, Inc.的1.7倍（$196.0M vs $117.7M），Resolute Holdings Management, Inc.净利率更高（-1.5% vs -14.6%，领先13.1%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $-18.7M）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
AXSM vs RHLD — 直观对比
营收规模更大
AXSM
是对方的1.7倍
$117.7M
净利率更高
RHLD
高出13.1%
-14.6%
自由现金流更多
RHLD
多$208.0M
$-18.7M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $117.7M |
| 净利润 | $-28.6M | $-1.7M |
| 毛利率 | — | 55.7% |
| 营业利润率 | -13.8% | 30.2% |
| 净利率 | -14.6% | -1.5% |
| 营收同比 | 65.0% | — |
| 净利润同比 | 61.9% | — |
| 每股收益（稀释后） | $-0.55 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMRHLD
| Q4 25 | $196.0M | $117.7M | ||
| Q3 25 | $171.0M | $120.9M | ||
| Q2 25 | $150.0M | $119.6M | ||
| Q1 25 | $121.5M | $103.9M | ||
| Q4 24 | $118.8M | — | ||
| Q3 24 | $104.8M | — | ||
| Q2 24 | $87.2M | — | ||
| Q1 24 | $75.0M | — |
净利润AXSMRHLD
| Q4 25 | $-28.6M | $-1.7M | ||
| Q3 25 | $-47.2M | $-231.0K | ||
| Q2 25 | $-48.0M | $-611.0K | ||
| Q1 25 | $-59.4M | $-3.4M | ||
| Q4 24 | $-74.9M | — | ||
| Q3 24 | $-64.6M | — | ||
| Q2 24 | $-79.3M | — | ||
| Q1 24 | $-68.4M | — |
毛利率AXSMRHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率AXSMRHLD
| Q4 25 | -13.8% | 30.2% | ||
| Q3 25 | -27.0% | 34.3% | ||
| Q2 25 | -24.5% | 34.0% | ||
| Q1 25 | -46.9% | 24.7% | ||
| Q4 24 | -61.1% | — | ||
| Q3 24 | -59.8% | — | ||
| Q2 24 | -89.5% | — | ||
| Q1 24 | -89.7% | — |
净利率AXSMRHLD
| Q4 25 | -14.6% | -1.5% | ||
| Q3 25 | -27.6% | -0.2% | ||
| Q2 25 | -32.0% | -0.5% | ||
| Q1 25 | -48.9% | -3.2% | ||
| Q4 24 | -63.1% | — | ||
| Q3 24 | -61.7% | — | ||
| Q2 24 | -91.0% | — | ||
| Q1 24 | -91.1% | — |
每股收益（稀释后）AXSMRHLD
| Q4 25 | $-0.55 | $-0.20 | ||
| Q3 25 | $-0.94 | $-0.03 | ||
| Q2 25 | $-0.97 | $-0.07 | ||
| Q1 25 | $-1.22 | $-0.39 | ||
| Q4 24 | $-1.54 | — | ||
| Q3 24 | $-1.34 | — | ||
| Q2 24 | $-1.67 | — | ||
| Q1 24 | $-1.44 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $88.3M | $6.5M |
| 总资产 | $689.8M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资AXSMRHLD
| Q4 25 | $322.9M | $205.5M | ||
| Q3 25 | $325.3M | $148.0M | ||
| Q2 25 | $303.0M | $99.9M | ||
| Q1 25 | $300.9M | $71.0M | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $315.7M | — | ||
| Q1 24 | $331.4M | — |
总债务AXSMRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AXSMRHLD
| Q4 25 | $88.3M | $6.5M | ||
| Q3 25 | $73.7M | $10.8M | ||
| Q2 25 | $73.1M | $9.6M | ||
| Q1 25 | $53.2M | $8.9M | ||
| Q4 24 | $57.0M | — | ||
| Q3 24 | $92.9M | — | ||
| Q2 24 | $102.9M | — | ||
| Q1 24 | $144.0M | — |
总资产AXSMRHLD
| Q4 25 | $689.8M | $333.4M | ||
| Q3 25 | $669.3M | $293.2M | ||
| Q2 25 | $639.8M | $253.3M | ||
| Q1 25 | $596.7M | $214.3M | ||
| Q4 24 | $568.5M | — | ||
| Q3 24 | $561.5M | — | ||
| Q2 24 | $548.2M | — | ||
| Q1 24 | $545.7M | — |
负债/权益比AXSMRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $189.2M |
| 自由现金流率自由现金流/营收 | -9.6% | 160.8% |
| 资本支出强度资本支出/营收 | 0.0% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $313.2M |
8季度趋势，按日历期对齐
经营现金流AXSMRHLD
| Q4 25 | $-18.7M | $196.1M | ||
| Q3 25 | $1.0M | $59.6M | ||
| Q2 25 | $-32.4M | $48.9M | ||
| Q1 25 | $-43.4M | $18.4M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.6M | — | ||
| Q2 24 | $-30.1M | — | ||
| Q1 24 | $-53.5M | — |
自由现金流AXSMRHLD
| Q4 25 | $-18.7M | $189.2M | ||
| Q3 25 | $988.0K | $58.6M | ||
| Q2 25 | $-32.4M | $47.5M | ||
| Q1 25 | $-43.7M | $17.8M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-30.2M | — | ||
| Q1 24 | $-53.6M | — |
自由现金流率AXSMRHLD
| Q4 25 | -9.6% | 160.8% | ||
| Q3 25 | 0.6% | 48.5% | ||
| Q2 25 | -21.6% | 39.7% | ||
| Q1 25 | -36.0% | 17.1% | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — | ||
| Q1 24 | -71.4% | — |
资本支出强度AXSMRHLD
| Q4 25 | 0.0% | 5.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.3% | 0.6% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
